Long-term miglitol administration suppresses postprandial glucose-dependent insulinotropic polypeptide secretion-Reference-Cited by-同舟云学术

Long-term miglitol administration suppresses postprandial glucose-dependent insulinotropic polypeptide secretion

Published:2013-04-05 Issue:3 Volume:4 Page:190-196
ISSN:2190-1678
Container-title:Diabetology International
language:en
Short-container-title:Diabetol Int

Author:

Sumi Keisuke,Ohkura Tsuyoshi,Yamamoto Naoya,Fujioka Youhei,Matsuzawa Kazuhiko,Izawa Shoichiro,Shiochi Hideki,Kinoshita Hiroshi,Ohkura Hiroko,Kato Masahiko,Yamamoto Kazuhiro,Taniguchi Shin-ichi

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13340-013-0116-0.pdf

Reference24 articles.

1. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M, STOP-NIDDM Trail Research Group. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. 2002;359:2072–7.

2. Narita T, Katsuura Y, Sato T. Miglitol induces prolonged and enhanced glucagon-like peptide-1 and reduced gastric inhibitory polypeptide responses after ingestion of a mixed meal in Japanese type 2 diabetic patients. Diabet Med. 2009;26:187–8.

3. Lee A, Patrick P, Wishart J, Horowitz M, Morley JE. The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics. Diabetes Obes Metab. 2002;4:329–35.

4. Yamada Y, Miyawaki K, Tsukiyama K, Harada N, Yamada C, Seino Y. Pancreatic and extrapancreatic effects of gastric inhibitory polypeptide. Diabetes. 2006;55:86–91.

5. Gault VA, McClean PL, Cassidy RS, Irwin N, Flatt PR. Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets. Diabetologia. 2007;50:1752–62.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Importance of Postprandial Glucose in Relation to A1C and Cardiovascular Disease;Clinical Diabetes;2019-07-01

2. Ipragliflozin: A novel sodium-glucose cotransporter 2 inhibitor developed in Japan;World Journal of Diabetes;2015

3. Bezafibrate improves insulin resistance evaluated using the glucose clamp technique in patients with type 2 diabetes mellitus: a small-scale clinical study;Diabetology & Metabolic Syndrome;2014-10-17

4. Low serum galectin-3 concentrations are associated with insulin resistance in patients with type 2 diabetes mellitus;Diabetology & Metabolic Syndrome;2014-09-27

5. Sitagliptin Improves the Impaired Acute Insulin Response during a Meal Tolerance Test in Japanese Patients with Type 2 Diabetes Mellitus: A Small-Scale Real-World Study;Diabetes Therapy;2014-06